Moody's affirms Yale New Haven Health's 'Aa3' rating

Moody's Investors Service affirmed the long-term underlying "Aa3" ratings of Yale New Haven (Conn.) Health, affecting $715 million of rated debt.

The rating reflects Moody's expectation that the system will continue to enjoy its leading market position in Connecticut along with the strong brand recognition associated with Yale University. Yale New Haven Health not only has a broad reach for tertiary and quaternary patients throughout the state but has been expanding its presence through consolidation.

The rating outlook is stable.

More articles on healthcare finance:

A recession is coming: What it could mean for healthcare
CHS expects $900M gain from hospital divestitures in 2019
Pennsylvania hospital employees work without pay

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Whitepapers

Featured Webinars